Insulin glargine solostar U300 1.5ML
Ended Awarded
- Contract number
- SPE2DR26F92ZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,190
Award facts
- Contract value 100% obligated
- $2,189.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp on July 27, 2026, with a ceiling value of $2,189.69, for insulin glargine SoloStar U300 1.5mL. The order is firm fixed price, with an ultimate completion date of July 28, 2026. Place of performance is Conshohocken, Pennsylvania 19428. The order was not set aside, and the prime holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26F92ZL?
SPE2DR26F92ZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 27, 2026.
How much is contract SPE2DR26F92ZL worth?
The government has obligated $2,190 on SPE2DR26F92ZL.
Is contract SPE2DR26F92ZL an order under another contract?
Yes. SPE2DR26F92ZL is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F92ZL competed?
The extent of competition for SPE2DR26F92ZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award